Beckman to automate Tandem assays on Sanofi's Access immunochemistry platform.
This article was originally published in The Gray Sheet
Executive Summary
BECKMAN'S ACQUISITION OF SANOFI'S ACCESS IMMUNOCHEMISTRY SYSTEM will give Beckman a more sensitive automated platform on which to run its Tandem line of monoclonal antibody-based diagnostic tests. The agreement, announced jointly on March 25, is expected to close April 30.